Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-17

FDA Approved: GABAPENTIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for gabapentin, a generic version of the anticonvulsant used for partial seizures and postherpetic neu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)